⌘K
Loading ticker…
Biohaven Ltd. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Biohaven Ltd. (BHVN) has a 3-month relative strength percentile of 94 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 64. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 8.3%, relative volume 2.48×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 94, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
BHVN appears in 1 ETF as of Mar 2026: VXF at 0.01% weight, $11M notional.
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VXFVanguard Extended Market ETF | 0.01% | $11M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BHVN Jan avg: 12.16% median: 4.35% win: 100% σ: 16.94% n: 4 2022-04-12 → 2026-05-29 | BHVN Feb avg: -4.29% median: -2.71% win: 25% σ: 11.65% n: 4 2022-04-12 → 2026-05-29 | BHVN Mar avg: -14.72% median: -18.58% win: 25% σ: 21.49% n: 4 2022-04-12 → 2026-05-29 | BHVN Apr avg: -9.30% median: -7.99% win: 20% σ: 15.94% n: 5 2022-04-12 → 2026-05-29 | BHVN May avg: 13.46% median: 14.81% win: 60% σ: 36.70% n: 5 2022-04-12 → 2026-05-29 | BHVN Jun avg: 8.04% median: 0.13% win: 50% σ: 19.21% n: 4 2022-04-12 → 2026-05-29 (current) | BHVN Jul avg: 0.91% median: 3.62% win: 75% σ: 13.02% n: 4 2022-04-12 → 2026-05-29 | BHVN Aug avg: -0.91% median: 1.05% win: 75% σ: 4.82% n: 4 2022-04-12 → 2026-05-29 | BHVN Sep avg: 16.95% median: 14.02% win: 75% σ: 21.29% n: 4 2022-04-12 → 2026-05-29 | BHVN Oct avg: -18.24% median: 0.75% win: 50% σ: 47.66% n: 4 2022-04-12 → 2026-05-29 | BHVN Nov avg: -7.02% median: -6.03% win: 25% σ: 27.56% n: 4 2022-04-12 → 2026-05-29 | BHVN Dec avg: 2.48% median: 0.15% win: 50% σ: 21.96% n: 4 2022-04-12 → 2026-05-29 |